RH Bophelo

Name

RH Bophelo

Legal name

RH Bophelo Limited

Website

https://rhbophelo.co.za

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

RH Bophelo Limited is a Johannesburg-based, JSE- and Rwanda-listed healthcare investment holding company that acquires, owns and manages hospitals and adjacent health-services businesses across South Africa to provide affordable private healthcare and financial services to under-served populations.

Ownership category

akta.pro rank

Product category

Healthcare Investment and Hospital Management

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Finance and Insurance (52), Portfolio Management and Investment Advice (523940)

SIC

Services-Hospitals (8060), Accident & Health Insurance (6321), Hospital & Medical Service Plans (6324), Investment Advice (6282)

akta.pro primary industry

Healthcare Offices BOP (Medical/Dental/Vet Clinics) (FSAJAFAL)

akta.pro secondary industries

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Healthcare & Pharmaceuticals (FSABACAN)

Keywords

• Healthcare investment
• Hospital acquisition
• Medical facility management
• Healthcare insurance underwriting
• Asset-light healthcare

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Investment Returns and Capital Gains: RH Bophelo generates returns through equity investments in healthcare assets. The company pursues active management of investment life cycles to maximise financial returns through appropriate exit mechanisms at maturity. For strong positive cash flow investee companies, active growth strategies are pursued or high dividend distributions are targeted to create annuity type income. Equity realisation may occur through initial public offerings and listing of shares on the JSE.
2. Hospital Management Fees: Through Africa Healthcare (AHC) and other operating entities, RH Bophelo earns management fees from operating and managing hospital facilities. AHC provides administration, commissioning, management and hospital infrastructure asset services.
3. Dividend Income: The company generates dividend income from its portfolio of healthcare investments and announced its second dividend in company history of R20 million in December 2023, demonstrating commitment to delivering shareholder value.
4. Insurance and Financial Services: Through Wesmart Financial Services (60% owned), RH Bophelo provides healthcare insurance underwriting agency services offering affordable healthcare insurance products. Through Genric Insurance (25% stake), niche insurance solutions are provided to healthcare ecosystem participants.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

RH Bophelo is a healthcare-focused investment holding company that acquires, owns and manages hospital and healthcare service businesses across South Africa. Through subsidiaries such as Africa Healthcare (AHC) and Wesmart, it provides hospital management, healthcare insurance underwriting, and increasingly asset-light healthcare service investments (pharmacy distribution, radiology, dialysis) to generate investment returns and address affordable healthcare access gaps.

Product overview

RH Bophelo operates as a pan-African healthcare investment holding company with a portfolio of hospital assets and healthcare-related services. The company owns and manages acute care hospitals, psychiatric facilities, day hospitals, and specialty healthcare services including pharmacy distribution, radiology, and dialysis. The portfolio includes 9 directly owned hospitals, 5 managed hospitals, and co-funded development of 15 hospitals. Key products include Africa Health Care (hospital operations and management), the Wesmart financial services platform for healthcare benefits administration, and Genric Insurance for niche insurance solutions. The company is transitioning to an asset-light strategy, expanding into value-added healthcare services such as dialysis (Renal Healthcare Africa JV), radiology (RazoHealth), and pharmaceutical distribution (MMed Distribution Services).

Differentiator

Problem solved

Functional benefit

Products and services

• Africa Healthcare (AHC) A majority Black and Women-owned healthcare management company acquired at 60% equity by RH Bophelo. Provides administration, commissioning, management and hospital infrastructure asset services for hospital facilities in the portfolio.
• Vryburg Private Hospital (VPH) 44-bed private hospital in Vryburg, North West Province – the only hospital within a 150km radius – with 18 doctors and 2 operating theatres, providing medical, surgical and casualty services to the local community.
• Rondebosch Medical Centre (RMC) Acute 123-bed independent private hospital in Rondebosch, Cape Town, with capacity to expand to above 200 beds, offering a full range of acute clinical services.
• RH Fauchard Hospital 16-bed day hospital facility in Roodepoort on the West Rand, serving as a test-bed for the company's day-hospital offering format.
• Medicare Private Hospital Acute 117-bed independent private hospital in Rustenburg, North West Province, providing 24/7 casualty, ICU, neonatal ICU, theatre, maternity and dialysis services, with expansion opportunity for an additional 30 to 60 beds.
• RH Bell Hospital 51-bed private psychiatric hospital in Krugersdorp specialising in psychiatric care, with supporting GP, dental, dermatology and orthopaedic services and on-site radiology.
• Wesmart Financial and Administration Solutions Authorised Financial Services Provider (60% RH Bophelo owned) offering off-the-shelf and tailor-made healthcare benefit solutions to corporate employers for primary and tertiary healthcare coverage of their employees.
• Renal Healthcare Africa JV Joint venture focused on expanding access to dialysis services across South Africa, addressing the rising burden of kidney disease as part of RH Bophelo's asset-light healthcare services portfolio.
• RazoHealth Radiology Managed radiology practice investment broadening access to diagnostic imaging services across the RH Bophelo hospital network.
• MMed Distribution Services Pharmaceutical distribution network investment improving medicine availability and supply across the RH Bophelo hospital portfolio.

Quantifiable outcome

• NAV growth from R500 million to R1.078 billion since listing in 2017, targeting R2 billion medium-term
• +4 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and secondary.

• Department of Health (South Africa)coreStrategic or Co-development Partner · 11 March 2020RH Group designated five hospitals as COVID-19 sites across five provinces to support Department of Health capacity to contain the virus. Hospitals made available for specialized COVID-19 treatment including intensive care facilities.
• Wesmart Financial ServicessecondaryStrategic or Co-development Partner · 30 April 2019RH Bophelo holds 60% of Wesmart, a registered Financial Services Provider providing off-the-shelf and tailor-made healthcare benefit solutions to corporate employers for primary and tertiary healthcare coverage of employees.
• Razorite Healthcare and Rehabilitation FundcoreStrategic or Co-development PartnerThe Razorite Healthcare and Rehabilitation Fund is the only institution in South Africa with sole mandate to provide equity for hospital construction financing. The fund does not have enough committed capital to fund all projects in its pipeline, presenting co-investment opportunities for RH Bophelo.
• Africa Healthcare (AHC)coreStrategic or Co-development PartnerAHC is a majority Black and Women-owned hospital management company acquired at 60% equity. AHC provides administration, commissioning, management, and hospital infrastructure assets. Primary divisions include hospitals, pharmacy, facilities management, emergency services, and nursing college.
• Genric InsurancecoreStrategic or Co-development PartnerRH Bophelo acquired 25% of Genric Insurance to build an interconnected healthcare ecosystem. Genric provides niche insurance solutions through specialist underwriting management agencies, enabling RH Bophelo to offer healthcare to insurance products and insure infrastructure, equipment, patients, and doctors.
• DeloittesecondaryImplementation/ SI/ Consulting PartnerProfessional services firm providing audit and advisory services to RH Bophelo.
• ENSafricasecondaryImplementation/ SI/ Consulting PartnerLeading African law firm providing legal advisory services.
• Birkett Stewart McHendriesecondaryImplementation/ SI/ Consulting PartnerProfessional services firm providing advisory services.
• Motsoeneng Bill AttorneyssecondaryImplementation/ SI/ Consulting PartnerLegal advisory services provider.
• Renal Healthcare Africa JVcoreStrategic or Co-development PartnerJoint venture for expanding access to dialysis services, addressing critical need given rising burden of kidney disease in South Africa.
• RazoHealth RadiologycoreStrategic or Co-development PartnerManaged radiology practice investment broadening access to diagnostic imaging services.
• MMed Distribution ServicescoreStrategic or Co-development PartnerPharmaceutical distribution network investment improving medicine availability across hospital network.

Scale indicators15 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Netcare Limited: Largest private hospital and healthcare operator in South Africa and the UK (Netcare, BMI Healthcare). Directly comparable to RH Bophelo's hospital investment thesis, although much larger, more established and operating on an asset-heavy basis.
• Life Healthcare Group: JSE-listed private hospital operator with a significant South African and southern African footprint. Comparable as a listed equity vehicle giving investors exposure to private hospital consolidation in the same market RH Bophelo targets.
• Mediclinic International: South Africa-origin, now London-listed private hospital group operating across SA, Namibia, Switzerland and the UAE. Comparable business model (acquisition and operation of acute private hospitals) and similar investor base via dual-listing strategy.
• Advanced Health: South African day-hospital and surgical centre operator focused on lower-cost, mid-tier private healthcare. Direct comparison for RH Bophelo's day-hospital strategy (e.g. RH Fauchard 16-bed day facility) and its affordable-care positioning.

Broad incumbents

• Discovery Limited: JSE-listed health-insurance, life-insurance and investment conglomerate anchored by Discovery Health. Comparable healthcare and insurance vertical overlap with RH Bophelo's Wesmart and former Genric Insurance exposure, though much broader and incumbent.
• Aspen Pharmacare: Africa's largest pharmaceutical manufacturer and distributor headquartered in Durban. Adjacent for the pharmaceutical distribution vertical (MMed Distribution) within RH Bophelo's asset-light strategy.
• Old Mutual Alternative Investments: South African institutional investor and acquirer of Genric Insurance (100%) in 2019. Comparable as a capital partner and insurance operator adjacent to RH Bophelo's former Genric stake and current Wesmart platform.

Emerging players

• Cure Day Hospitals: South African day-hospital network focused on same-day surgical procedures in the lower-to-mid private market. Niche overlap with RH Bophelo's day-hospital test bed at RH Fauchard and broader mid-tier hospital thesis.
• CCH Investment Holdings (Africa Healthcare Holdings): Africa-focused healthcare investment consortium pursuing hospital and diagnostics acquisitions across the continent. Similar investment-holding structure and African healthcare roll-up thesis to RH Bophelo, albeit at an earlier stage.

Others

• Actis: Emerging-markets private equity firm with active healthcare investment platforms across Africa and Asia. Comparable as a long-term institutional capital allocator targeting African healthcare assets, but as a fund manager rather than a listed holding company.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/RHBophelo
• Facebookfacebook.com/RHBopheloZA

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RH Bophelo